Delay in hospital admission of patients with cerebral vein and dural sinus thrombosis

Cerebrovascular Diseases

Volumn 19, Issue 3, 2005, Pages 152-156

  Ferro, José M ^a,e   Lopes, M G ^b   Rosas, M J ^c   Fontes, J ^d  

^a HOSPITAL DE SANTA MARIA   (Portugal)

^b HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^c HOSPITAL DE SÃO JOÃO   (Portugal)

^d HOSPITAL DE BRAGA   (Portugal)

^e Centro de Estudos Egas Moniz   (Portugal)

Author keywords

Admission delay; Durai sinus thrombosis; Intracranial hypertension

Indexed keywords

ANTICOAGULANT AGENT;

ADULT; ANTICOAGULATION; ARTICLE; BRAIN VEIN; CEREBRAL SINUS THROMBOSIS; CONFIDENCE INTERVAL; DELIRIUM; DURA MATER; FEMALE; HEADACHE; HOSPITAL ADMISSION; HUMAN; INTRACRANIAL HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HEALTH; OCCLUSIVE CEREBROVASCULAR DISEASE; PAPILLEDEMA; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; TIME SERIES ANALYSIS; HOSPITALIZATION; MIDDLE AGED; PORTUGAL; STATISTICS; TIME; VASCULARIZATION;

ANTICOAGULANTS; DURA MATER; FEMALE; HOSPITALIZATION; HUMANS; INTRACRANIAL HYPERTENSION; INTRACRANIAL THROMBOSIS; MALE; MIDDLE AGED; PATIENT ADMISSION; PORTUGAL; SEVERITY OF ILLNESS INDEX; SINUS THROMBOSIS, INTRACRANIAL; TIME FACTORS;

EID: 17444366158     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083248     Document Type: Article

References (22)

1. Davalos A, Castillo J, Martinez-Vila E: Delay in neurological attention and stroke outcome. Cerebrovascular Diseases Study Group of the Spanish Society of Neurology. Stroke 1995;26: 2233-2237.
2. Jorgensen HS, Nakayama H, Reith J, Raaschou HO, Olsen TS: Factors delaying hospital admission in acute stroke: The Copenhagen Stroke Study. Neurology 1996;47:383-387.
3. Wester P, Radberg J, Lundgreen B, Peltonen M: Factors associated with delayed admission to hospital and in-hospital delays in acute stroke and TIA. A prospective, multicenter study. Stroke 1999;30:40-48.
4. Wester P, Radberg J, Lundgren B, Peltonen M: Factors associated with delayed admission to hospital and in-hospital delays in acute stroke and TIA: A prospective, multicenter study. Seek-Medical-Attention-in-Time Study Group. Stroke 1999;30:40-48.
5. Lacy CR, Suh DC, Bueno M, Kostis JB: Delay in presentation and evaluation for acute stroke. Stroke Time Registry for Outcomes Knowledge and Epidemiology (S.T.R.O.K.E.). Stroke 2001;32:63-69.
6. Nedeltchev K, Arnold M, Brekenfeld C, Isenegger J, Remonda L, Schroth G, Mattle HP: Pre- and in-hospital delays from stroke onset to intra-arterial thrombolysis. Stroke 2003;34:1230-1234.
7. Kassell NF, Kongable GL, Torner JC, Adams HP, Mazuz H: Delay in referral of patients with ruptured aneurysm to neurosurgical attention. Stroke 1985;16:587-594.
8. Schievink WI, Werf DJM, Hageman LM, Dreissen JJR: Referral pattern of patients with aneurismal subarachnoid hemorrhage. Surg Neurol 1988;29:367-371.
9. Ferro JM, Lopes J, Melo TP, Oliveira V, Crespo M, Campos JG, Trindade A, Antunes JL: Investigation into the causes of delayed diagnosis of subarachnoid hemorrhage. Cerebrovasc Dis 1991;1:160-164.
10. Edner G, Ronne-Engstrom E: Can early admission reduce aneurysmal rebleeds? A prospective study on aneurysmal incidence, aneurysmal rebleeds, admission and treatment delays in a defined region. Br J Neurosurg 1991;5:601-608.
11. Stam J, de Bruijn SFTM, DeVeber G: Anticoagulation for cerebral sinus thrombosis. Cochrane Database Syst Rev 2002(4):CD002005.
12. Canhão P, Falcão F, Ferro JM: Thrombolytics for cerebral sinus thrombosis. A systematic review. Cerebrovasc Dis 2003;15:159-166.
13. Crassard I, Canhão P, Ferro JM, Bousser MG, Barinagarrementeria F, Stam J: Neurological worsening in the acute phase of cerebral venous thrombosis in ISCVT (International Study on Cerebral Venous Thrombosis). Cerebrovasc Dis 2003;15(suppl 4):60.
14. Ferro JM, Correia M, Pontes C, Baptista MV, Pita F for the Cerebral Venous Thrombosis Portuguese Collaborative Study Group (VENOPORT): Cerebral vein and dural sinus thrombosis in Portugal: 1980-1998. Results of the VENOPORT study. Cerebrovasc Dis 2001;11:177-182.
15. Bamford JM, Sandercock PA, Warlow CP, Slattery J: Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1989;20:828.
16. Ferro JM, Lopes MG, Rosas MJ, Ferro MA, Fontes J for the Cerebral Venous Thrombosis Portuguese Collaborative Study Group (VENOPORT): Long-term prognosis of cerebral vein and dural sinus thrombosis. Results of the VENOPORT study. Cerebrovasc Dis 2002;13:272-278.
17. Breteau G, Mounier-Vehier F, Godefroy O, Gauvrit J-L, Mackowiak-Cordoliani M-A, Girot M, Bertheloot D, Hénon H, Lucas C, Leclerc X, Fourrier F, Pruvo JP, Leys D: Cerebral venous thrombosis. Three-year clinical outcome in 55 consecutive patients. J Neurol 2003;250:29-35.
18. Einhäupl KM, Villringer A, Meister W, Mehraein S, Garner C, Pellkofer M, Haberl RL, Pfister H-W, Schmiedek P: Heparin treatment in sinus venous thrombosis. Lancet 1991;338:597-600.
19. De Bruijn SFTM, Stam J, for the Cerebral Venous Thrombosis Study Group: Randomised, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 1999;30:484-488.
20. Rondepierre P, Hamon M, Leys D, Lederc X, Mournier-Vehrer F, Godefroy O, Janssens E, Pruvo JP: Thromboses veineuses cérébrales: étude de l'évolution. Rev Neurol 1995;151:100-104.
21. Lalive PH, de Moerloose P, Lovblad K, Sarasin FP, Mermillod B, Sztajzel: Is measurement of D-dimer useful in the diagnosis of cerebral venous thrombosis? Neurology 2003;61:1057-1060.
22. Talbot K, Wright M, Keeling D: Normal D-dimer levels do not exclude the diagnosis of cerebral venous sinus thrombosis. J Neurol 2002;249:1603-1604.